Responses
Regular and Young Investigator Award Abstracts
Immune-Stimulants and Immune Modulators
772 MHC-I skewing in mutant calreticulin-positive myeloproliferative neoplasms is countered by heteroclitic peptide cancer vaccination
Compose a Response to This Article
Other responses
No responses have been published for this article.